Abeona Therapeutics logo
Abeona Therapeutics ABEO
$ 5.68 0.89%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Abeona Therapeutics Balance Sheet 2011-2024 | ABEO

Annual Balance Sheet Abeona Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-9.07 M -6.59 M -23.6 M -10.8 M -121 M 11.2 M -138 M -69.1 M -36.1 M -7.12 M -424 K -396 K 290 K

Long Term Debt

4.4 M 5.85 M 7.56 M 1.43 M - 20 M - - 4 M 4 M - - -

Long Term Debt Current

998 K 1.77 M 1.82 M 1.71 M 1.7 M - - - - - - - -

Total Non Current Liabilities

- - - 6.69 M 6.25 M 20 M 3.06 M 3.66 M 10.9 M 8.87 M 6.43 M 12.2 M 9.2 M

Total Current Liabilities

13.4 M 7.78 M 16.6 M 42 M 38.7 M 20.4 M 5.61 M 8.3 M 1.48 M 2.9 M 8.96 M 6.63 M 12.2 M

Total Liabilities

49.2 M 37.5 M 37.2 M 48.6 M 45 M 40.4 M 8.67 M 12 M 12.3 M 11.8 M 15.4 M 18.8 M 21.4 M

Deferred Revenue

- - - 296 K 296 K 296 K 3.21 M 602 K 602 K 602 K 578 K 247 K 285 K

Retained Earnings

-750 M -695 M -656 M -571 M -486 M -410 M -360 M -332 M -311 M -296 M -266 M -268 M -255 M

Total Assets

64 M 64.2 M 79.6 M 151 M 223 M 174 M 179 M 111 M 80.1 M 16.6 M 613 K 1.73 M 3.78 M

Cash and Cash Equivalents

14.5 M 14.2 M 32.9 M 12.6 M 129 M 18.8 M 138 M 69.1 M 40.1 M 11.5 M 424 K 396 K 2.46 M

Book Value

14.8 M 26.8 M 42.4 M 103 M 178 M 134 M 170 M 99.1 M 67.7 M 4.82 M -14.8 M -17.1 M -17.6 M

Total Shareholders Equity

14.8 M 26.8 M 42.4 M 103 M 178 M 134 M 170 M 99.1 M 67.7 M 4.82 M -14.8 M -17.1 M -17.6 M

All numbers in USD currency

Quarterly Balance Sheet Abeona Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

14.2 M 16.1 M 18.1 M 4.4 M 4.04 M 4.38 M 5.53 M 5.85 M 6.48 M 6.74 M 7.27 M 7.56 M 4.44 M 4.72 M 4.99 M 5.26 M 5.26 M 5.26 M 5.26 M 6.25 M 6.25 M 6.71 M 6.93 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 2.75 M -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

74.8 M 60.8 M 83.7 M 49.2 M 44 M 44.2 M 34.6 M 37.5 M 23.3 M 24.6 M 23.7 M 28.2 M 39.3 M 46.6 M 47 M 48.6 M 48.6 M 48.6 M 48.6 M 45 M 45 M 45 M 45 M 40.4 M 40.4 M 40.4 M 40.4 M 8.67 M 8.67 M 8.67 M 8.67 M 12 M 12 M 12 M 12 M 12.3 M 12.3 M 12.3 M 12.3 M 11.8 M 11.8 M 11.8 M 11.8 M 15.4 M 15.4 M 15.4 M 15.4 M 18.8 M 18.8 M 18.8 M 18.8 M 21.4 M 21.4 M 21.4 M 21.4 M

Deferred Revenue

- - - - - - - - - - - 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 296 K 2.6 M 3.21 M 3.21 M 3.21 M 602 K 602 K 602 K 602 K 602 K 602 K 602 K 602 K 602 K 602 K 602 K 602 K 578 K 578 K 578 K 578 K 247 K 247 K 247 K 247 K 285 K 285 K 285 K 285 K

Retained Earnings

-804 M -774 M -781 M -750 M -733 M -721 M -704 M -695 M 688 M -685 M -676 M -656 M -609 M -602 M -587 M -571 M -571 M -571 M -571 M -486 M -486 M -486 M -486 M -410 M -410 M -410 M -410 M -360 M -360 M -360 M -360 M -332 M -332 M -332 M -332 M -311 M -311 M -311 M -311 M -296 M -296 M -296 M -296 M -266 M -266 M -266 M -266 M -268 M -268 M -268 M -268 M -255 M -255 M -255 M -255 M

Total Assets

121 M 134 M 74.8 M 64 M 66.1 M 53.6 M 53.3 M 64.2 M 38.8 M 44.7 M 55.2 M 79.6 M 119 M 131 M 141 M 151 M 151 M 151 M 151 M 223 M 223 M 223 M 223 M 174 M 174 M 174 M 174 M 179 M 179 M 179 M 179 M 111 M 111 M 111 M 111 M 80.1 M 80.1 M 80.1 M 80.1 M 16.6 M 16.6 M 16.6 M 16.6 M 613 K 613 K 613 K 613 K 1.73 M 1.73 M 1.73 M 1.73 M 3.78 M 3.78 M 3.78 M 3.78 M

Cash and Cash Equivalents

15.7 M 34.4 M 17.6 M 14.5 M 4.71 M 6.22 M 4.68 M 14.2 M 5.73 M 6.13 M 20.3 M 32.9 M 43.8 M 27.2 M 14.3 M 12.6 M 12.6 M 12.6 M 12.6 M 129 M 129 M 129 M 129 M 18.8 M 18.8 M 18.8 M 18.8 M 138 M 138 M 138 M 138 M 69.1 M 69.1 M 69.1 M 69.1 M 40.1 M 40.1 M 40.1 M 40.1 M 11.5 M 11.5 M 11.5 M 11.5 M 424 K 424 K 424 K 424 K 396 K 396 K 396 K 396 K 2.46 M 2.46 M 2.46 M 2.46 M

Book Value

45.8 M 73.2 M -8.88 M 14.8 M 22 M 9.34 M 18.7 M 26.8 M 15.4 M 20.1 M 31.4 M 51.4 M 79.7 M 84.1 M 94.4 M 103 M 103 M 103 M 103 M 178 M 178 M 178 M 178 M 134 M 134 M 134 M 134 M 170 M 170 M 170 M 170 M 99.1 M 99.1 M 99.1 M 99.1 M 67.7 M 67.7 M 67.7 M 67.7 M 4.82 M 4.82 M 4.82 M 4.82 M -14.8 M -14.8 M -14.8 M -14.8 M -17.1 M -17.1 M -17.1 M -17.1 M -17.6 M -17.6 M -17.6 M -17.6 M

Total Shareholders Equity

45.8 M 73.2 M -8.88 M 14.8 M 22 M 9.34 M 18.7 M 26.8 M 12.4 M 14 M 21.2 M 51.4 M 79.7 M 84.1 M 94.4 M 103 M 103 M 103 M 103 M 178 M 178 M 178 M 178 M 134 M 134 M 134 M 134 M 170 M 170 M 170 M 170 M 99.1 M 99.1 M 99.1 M 99.1 M 67.7 M 67.7 M 67.7 M 67.7 M 4.82 M 4.82 M 4.82 M 4.82 M -14.8 M -14.8 M -14.8 M -14.8 M -17.1 M -17.1 M -17.1 M -17.1 M -17.6 M -17.6 M -17.6 M -17.6 M

All numbers in USD currency